Rheumatoid arthritis with ANCA associated vasculitis

Vikram Muralidhar Haridas, Kiran Haridas
DOI: 10.15305/ijrci/v6i1/273


Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) are rarely associated with autoimmune diseases. The present report describes an uncommon case of a 50-year old women with the co-occurrence of antineutrophil cytoplasmic antibody associated vasculitis with rheumatoid arthritis. The patient was treated with steroids and cyclophosamide and achieved complete recovery of the lesions, following 4-weeks of treatment.


Haridas V, Haridas K. IJRCI. 2018;4(1):CS7 DOI: 10.15305/ijrci/v6i1/273


Rheumatoid arthritis, ANCA, ANCA associated vasculitis, autoimmune diseases


1. Lazarus B, John GT, O’Callaghan C, Ranganathan D. Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis. Indian J Nephrol 2016;26(2):86–96.

2. Draibe J, Salama AD. Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome. Springerplus [Internet]. 2015 [cited 2018 Aug 22];4:50. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315802/

3. Johns Hopkins Vasculitis Center. Rheumatoid Vasculitis [Internet]. Johns Hopkins Vasculitis Center. [cited 2018 Aug 22]. Available from: https://www.hopkinsvasculitis.org/types-vasculitis/rheumatoid-vasculitis/

4. Vollertsen RS, Conn DL. Vasculitis associated with rheumatoid arthritis. Rheum Dis Clin North Am 1990;16(2):445–61.

5. Bartels CM, Bridges AJ. Rheumatoid Vasculitis: Vanishing Menace or Target for New Treatments? Curr Rheumatol Rep 2010;12(6):414–9.

6. Kallenberg CGM. Pathogenesis of ANCA-associated vasculitides. Ann Rheum Dis 2011;70 Suppl 1:i59-63.

7. McKinney EF, Willcocks LC, Broecker V, Smith KGC. The immunopathology of ANCA-associated vasculitis. Semin Immunopathol 2014;36(4):461–78.

8. ANCA-associated vasculitis | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program [Internet]. [cited 2018 Aug 22]. Available from: https://rarediseases.info.nih.gov/diseases/13011/anca-associated-vasculitis

9. Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 2013;12(4):477–82.

10. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337(21):1512–23.

11. Mansi IA, Opran A, Rosner F. ANCA-Associated Small-Vessel Vasculitis. Am Fam Physician 2002;65(8):1615-20.

12. Villacorta J, Díaz-Crespo F, Stanescu R, Fernandez-Juarez G. Large and Small vessel Severe Involvement in ANCA-Associated Vasculiitis. Journal of Vasculitis 2016;2(2):1–3.

13. Johansson M, Arlestig L, Hallmans G, Rantapää-Dahlqvist S. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res Ther 2006;8(1):R19.

14. Jagiello P, Aries P, Arning L, Wagenleiter SEN, Csernok E, Hellmich B, et al. The PTPN22 620W allele is a risk factor for Wegener’s granulomatosis. Arthritis Rheum 2005;52(12):4039–43.

15. Menegatti E, Davit A, Francica S, Berardi D, Rossi D, Baldovino S, et al. Genetic factors associated with rheumatoid arthritis and systemic vasculitis: Evaluation of a panel of polymorphisms. Dis Markers 2009;27(5):217–23.

16. Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 1979;301(5):235–8.

17. Yates M, Watts R. ANCA-associated vasculitis. Clin Med (Lond) 2017;17(1):60–4.

18. Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 2014;371(19):1771–80.